Clinical trials

  • LENALIDOMIDE for Multiple myeloma
  • TARLATAMAB for Small cell lung cancer | Relapsed/refractory small cell lung cancer
  • AMIVANTAMAB for Non-small cell lung cancer (EGFR-mutated, advanced or metastatic)
  • APALUTAMIDE for Prostate cancer | High-risk prostate adenocarcinoma after radical prostatectomy
  • DAPANSUTRILE for Type 2 diabetes mellitus
  • LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN for Metastatic castration-resistant prostate cancer (mCRPC)|Metastatic prostate cancer
  • GIVINOSTAT for Duchenne muscular dystrophy
  • Anifrolumab for Non-segmental vitiligo
  • Dapagliflozin propanediol for Type 2 diabetes mellitus
  • Molgramostim for Autoimmune pulmonary alveolar proteinosis | Pulmonary alveolar proteinosis
  • OXYGEN for Acute pulmonary embolism
  • ENCORAFENIB for Metastatic or unresectable locally advanced melanoma (BRAF V600E/K mutation-positive)